Press Releases Please click here if you wish to receive an e-mail notification regarding Alector press releases. Year None201920182017 Apr 17, 2019 Alector Announces First Frontotemporal Dementia Patient Dosed in Phase 1b Study of AL001 Apr 17, 2019 PDF Version Apr 01, 2019 Alector Initiates Phase 1 Trial of AL003 for the Treatment of Patients with Alzheimer’s Disease Apr 01, 2019 PDF Version Mar 26, 2019 Alector Reports Recent Business Highlights and Fourth Quarter and Full Year 2018 Financial Results Mar 26, 2019 PDF Version Mar 06, 2019 Alector to Present at Investor Conferences in March Mar 06, 2019 PDF Version Feb 06, 2019 Alector Announces Pricing of Initial Public Offering Feb 06, 2019 PDF Version
Apr 17, 2019 Alector Announces First Frontotemporal Dementia Patient Dosed in Phase 1b Study of AL001 Apr 17, 2019 PDF Version
Apr 01, 2019 Alector Initiates Phase 1 Trial of AL003 for the Treatment of Patients with Alzheimer’s Disease Apr 01, 2019 PDF Version
Mar 26, 2019 Alector Reports Recent Business Highlights and Fourth Quarter and Full Year 2018 Financial Results Mar 26, 2019 PDF Version